Results 31 to 40 of about 28,317 (188)

THE TREATMENT OF PERTUSSIS WITH VACCINE [PDF]

open access: yesArchives of Pediatrics & Adolescent Medicine, 1912
The seriousness of pertussis in the infant, its tendency to be complicated by pneumonia, emphysema, convulsions and perhaps paralysis, and the possibility of a fatal termination, have caused this disease to occupy a prominent place in the minds of all physicians, particularly as it is so commonly seen in infancy, 50 per cent.
openaire   +2 more sources

Seroepidemiology of pertussis in Hangzhou, China, during 2009–2017

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Objective: To delineate seroepidemiology of pertussis in Hangzhou, to evaluate the protection levels of pertussis among healthy populations, for improving prevention strategy of pertussis.Methods: During 2009–2017, a multistage stratified random sampling
Yuyang Xu   +10 more
doaj   +1 more source

Analysis of Carbohydrates and Glycoconjugates by Matrix‐Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023–2024

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley   +1 more source

What do Parents Learn by Reading a DPT Vaccine Information Form?

open access: yesCanadian Journal of Infectious Diseases, 1994
Objective: Information forms are commonly used to inform parents about childhood vaccination. This study assessed the knowledge of mothers about pertussis and pertussis vaccine before and after reading a form about diphtheria-pertussis-tetanus (dpt ...
Ronald Gold, Gordean L Bjornson
doaj   +1 more source

Acellular and "low" pertussis vaccines: adverse events and the role of mutations Vacinas pertussis acelular e pertussis "low": eventos adversos e o papel das mutações

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2009
Objective: to discuss the current PAHO recommendation that does not support the substitution of traditional cellular DTP vaccine by acellular DTP, and the role of mutations, in humans, as the main cause of rare adverse events, such as epileptic-like ...
Hisako G. Higashi   +6 more
doaj   +1 more source

Nasal vaccines for pertussis

open access: yesCurrent Opinion in Immunology, 2023
Whooping cough, caused by Bordetella pertussis, is still a major cause of morbidity and mortality worldwide. Current acellular pertussis (aP) vaccines induce potent circulating IgG and prevent severe disease in children/adults and in infants born to vaccinated mothers.
Pauline, Schmitt   +4 more
openaire   +3 more sources

Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture

open access: yesFrontiers in Immunology, 2021
Outer membrane vesicles (OMV) derived from Bordetella pertussis—the etiologic agent of the resurgent disease called pertussis—are safe and effective in preventing bacterial colonization in the lungs of immunized mice.
Francisco Carriquiriborde   +9 more
doaj   +1 more source

Swedish Infants Developed Pertussis at a Younger Age if Their Mother Was the Possible Source of Infection in 2009–2015

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim The aim of this study was to investigate the possible source of laboratory‐confirmed pertussis in infants under 6 months of age. Methods This nationwide prospective study was based on laboratory‐confirmed cases reported in the enhanced pertussis surveillance in Sweden from 2009 to 2015. The parents or carers of 345 infants were interviewed
Bernice Aronsson   +4 more
wiley   +1 more source

Vaccinations During Pregnancy Protect the Mother–Infant Dyad and Are Generally Safe

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Vaccination in pregnancy has a critical impact on mothers, foetuses and infants. The aim of this paper was to summarise key points presented by experts attending the 12th Maria Delivoria‐Papadopoulos Perinatal Symposium in March 2025 and further expand and update them.
Ariadne Malamitsi‐Puchner   +2 more
wiley   +1 more source

An Expert Perspective on a New Recombinant Pertussis-Only Vaccine and Its Potential Clinical and Programmatic Advantages in Australia, New Zealand, and Beyond

open access: yesVaccines
Despite high childhood coverage and booster doses of pertussis vaccination across the life course, pertussis (whooping cough) outbreaks continue to occur, including in Australia and New Zealand.
Peter McIntyre   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy